American College of Rheumatology Convergence 2020 Meeting Reporter

New findings show a unique series of markers could indicate particular black SLE patient risks.

A real-world study shows the therapy was slightly more efficacious for biologic-naive PsA patients.

The common rheumatic drug was found in a cohort analysis to be linked to greater regional TB outbreaks.